• Home
• Responsibility
• Our values and policies
• Valuing people
• Employee wellbeing
• Employee access to anti-retroviral drugs

Employee access to anti-retroviral drugs

We are committed to global leadership in protecting and promoting the health of our employees. We take this responsibility extremely seriously and we have comprehensive healthcare programmes in place in the many countries in which we operate.

The HIV/AIDS pandemic continues to spread around the world at an alarming rate and threatens to reverse decades of development growth. In recognition of this, we provide ARVs and facilitate care to all regular staff and their families in the developing world where existing medical coverage may not be as robust as that offered in developed world markets.

This commitment forms part of a broader programme of HIV/AIDS prevention, education and voluntary counselling and testing for staff, and is underpinned by our policy of non-discrimination towards employees diagnosed as HIV positive.

Responsibility for determining the specific arrangements for providing ARVs, medical care, testing and HIV/AIDS education programmes, rests with local Operating Units. They are best placed to determine the most culturally sensitive and practical way of delivering on the company’s commitment in-market.

This programme for our own employees is matched by our offer of preferentially priced ARVs to other employers in Sub-Sahara Africa who have their own workplace clinics or equivalent not-for-profit arrangements.

We are committed to regular reviews of our ARV Treatment programme for employees to ensure that it adequately reflects the changing nature and impact of the epidemic on our operations and staff.

Back to top